Annual Cash & Cash Equivalents
$2.58 M
+$1.29 M+100.62%
31 December 2023
Summary:
Panbela Therapeutics annual cash & cash equivalents is currently $2.58 million, with the most recent change of +$1.29 million (+100.62%) on 31 December 2023. During the last 3 years, it has fallen by -$9.29 million (-78.28%). PBLA annual cash & cash equivalents is now -78.28% below its all-time high of $11.87 million, reached on 31 December 2021.PBLA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$142.00 K
+$83.00 K+140.68%
30 September 2024
Summary:
Panbela Therapeutics quarterly cash and cash equivalents is currently $142.00 thousand, with the most recent change of +$83.00 thousand (+140.68%) on 30 September 2024. Over the past year, it has dropped by -$2.44 million (-94.49%). PBLA quarterly cash and cash equivalents is now -98.99% below its all-time high of $14.07 million, reached on 30 September 2021.PBLA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBLA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -94.5% |
| 3 y3 years | -78.3% | -98.8% |
| 5 y5 years | +5.3% | -94.2% |
PBLA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.3% | +100.6% | -98.8% | +140.7% |
| 5 y | 5 years | -78.3% | +100.6% | -99.0% | +140.7% |
| alltime | all time | -78.3% | +5282.1% | -99.0% | +192.2% |
Panbela Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $142.00 K(+140.7%) |
| June 2024 | - | $59.00 K(-77.5%) |
| Mar 2024 | - | $262.00 K(-89.8%) |
| Dec 2023 | $2.58 M(+100.6%) | $2.58 M(+184.2%) |
| Sept 2023 | - | $907.00 K(-87.4%) |
| June 2023 | - | $7.21 M(+37.6%) |
| Mar 2023 | - | $5.24 M(+307.4%) |
| Dec 2022 | $1.28 M(-89.2%) | $1.28 M(+36.6%) |
| Sept 2022 | - | $941.00 K(-62.8%) |
| June 2022 | - | $2.53 M(-65.7%) |
| Mar 2022 | - | $7.39 M(-37.8%) |
| Dec 2021 | $11.87 M(+31.5%) | $11.87 M(-15.7%) |
| Sept 2021 | - | $14.07 M(+119.7%) |
| June 2021 | - | $6.41 M(-20.9%) |
| Mar 2021 | - | $8.10 M(-10.2%) |
| Dec 2020 | $9.02 M(+268.4%) | $9.02 M(-17.0%) |
| Sept 2020 | - | $10.87 M(+379.9%) |
| June 2020 | - | $2.27 M(+74.8%) |
| Mar 2020 | - | $1.30 M(-47.1%) |
| Dec 2019 | $2.45 M(+74.3%) | $2.45 M(-27.5%) |
| Sept 2019 | - | $3.38 M(+368.4%) |
| June 2019 | - | $721.00 K(-47.7%) |
| Mar 2019 | - | $1.38 M(-1.9%) |
| Dec 2018 | $1.41 M | $1.41 M(+487.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $239.00 K(-73.6%) |
| June 2018 | - | $905.00 K(-22.6%) |
| Mar 2018 | - | $1.17 M(+669.1%) |
| Dec 2017 | $152.00 K(-65.3%) | $152.00 K(-83.9%) |
| Sept 2017 | - | $943.00 K(-21.0%) |
| June 2017 | - | $1.19 M(-51.1%) |
| Mar 2017 | - | $2.44 M(+457.5%) |
| Dec 2016 | $438.00 K(-52.6%) | $438.00 K(-64.4%) |
| Sept 2016 | - | $1.23 M(-35.2%) |
| June 2016 | - | $1.90 M(+395.6%) |
| Mar 2016 | - | $383.00 K(-58.6%) |
| Dec 2015 | $925.00 K(-44.1%) | $925.00 K(-48.2%) |
| Sept 2015 | - | $1.79 M(+2656.2%) |
| June 2015 | - | $64.80 K(-72.8%) |
| Mar 2015 | - | $238.20 K(-85.6%) |
| Dec 2014 | $1.65 M(+2712.9%) | $1.65 M(+1156.8%) |
| Sept 2014 | - | $131.60 K(+7.1%) |
| June 2014 | - | $122.90 K(+72.9%) |
| Mar 2014 | - | $71.10 K(+20.9%) |
| Dec 2013 | $58.80 K(-47.0%) | $58.80 K(-43.4%) |
| Sept 2013 | - | $103.80 K(+113.6%) |
| June 2013 | - | $48.60 K(-10.7%) |
| Mar 2013 | - | $54.40 K(-50.9%) |
| Dec 2012 | $110.90 K(+131.5%) | $110.90 K |
| Dec 2011 | $47.90 K | - |
FAQ
- What is Panbela Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Panbela Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of PBLA is $2.58 M
What is the all time high annual cash & cash equivalents for Panbela Therapeutics?
Panbela Therapeutics all-time high annual cash & cash equivalents is $11.87 M
What is Panbela Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PBLA is $142.00 K
What is the all time high quarterly cash and cash equivalents for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly cash and cash equivalents is $14.07 M
What is Panbela Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, PBLA quarterly cash and cash equivalents has changed by -$2.44 M (-94.49%)